Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01087554
Show Display Options
RSS Create an RSS feed from your search for:
NCT01087554
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer
Condition: Advanced Cancer
Interventions: Drug: Sirolimus;   Drug: Vorinostat;   Drug: Everolimus;   Drug: Temsirolimus

Study has passed its completion date and status has not been verified in more than two years.